Sequential multidisciplinary treatment of hepatocellular carcinoma: The role of surgery as rescue therapy for failure of percutaneous ablation therapies

Journal of Surgical Oncology

Volumn 100, Issue 7, 2009, Pages 580-584

  Portolani, Nazario ^a   Baiocchi, Gian Luca ^a   Coniglio, Arianna ^a   Grazioli, Luigi ^b   Frassi, Eleonora ^a   Gheza, Federico ^a   Giulini, Stefano Maria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b BRESCIA CIVIL HOSPITAL   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver resection; Percutaneous alcohol injection; Radiofrequency ablation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PERCUTANEOUS ABLATION; PRIORITY JOURNAL; RECURRENT CANCER; REOPERATION; SURVIVAL RATE; TREATMENT FAILURE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT FAILURE;

EID: 71549169908     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21375     Document Type: Article

References (32)

1. Chen MS, Li JQ, Zheng Y, et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-328. (Pubitemid 43327762)
2. Bruix J, Sherman M, Llovet JM, et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
3. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1234.
4. Lam CM, Ng KK, Poon RT, et al.: Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 2004;91:334-338. (Pubitemid 38375774)
5. Yokoyama T, Egami K, Miyamoto M, et al.: Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg 2003;10:425-427. (Pubitemid 38128791)
6. Ruzzenente A, Manzoni GD, Molfetta M, et al.: Rapid progression of hepatocellular carcinoma after radiofrequency ablation. World J Gastroenterol 2004;10:1137-1140. (Pubitemid 38559388)
7. Poon RT, Fan ST, Tsang FH, et al.: Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg 2002;235:466-486.
8. Lu MD, Yin XY, Xie XY, et al.: Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005;92:1393-1398. (Pubitemid 41546638)
9. Portolani N, Coniglio A, Ghidoni S, et al.: Early and late recurrence after liver resection for hepatocellular carcinoma: Prognostic and therapeutic implications. Ann Surg 2006;243:229-235. (Pubitemid 43185442)
10. Choi D, Lim HK, Kim MJ, et al.: Recurrent hepatocellular carcinoma: Percutaneous radiofrequency ablation after hepatectomy. Radiology 2004;230:135-141. (Pubitemid 37549794)
11. Chiesa R, Donato F, Portolani N, et al.: Primary liver cancer in a high incidence area in north Italy: Etiological hypothesis arising from routinely collected data. Eur J Epidemiol 1995;11:435-442.
12. Mazzaferro V, Romito R, Schiavo M, et al.: Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006;144:1543-1554. (Pubitemid 44970357)
13. Mau C, Liu CL, Chan SC, et al.: A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 2007;245:831-842.
14. Clavien PA: Interferon. The magic bullet to prevent hepatocellular carcinoma recurrence after resection? Ann Surg 2007;245:843-845.
15. Poon RTP, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24. (Pubitemid 30456545)
16. Nakajima Y, Kanamura T, Nagao M, et al.: Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 2001;192:339-344. (Pubitemid 32208875)
17. Taura K, Ikai I, Hatano E, et al.: Implications of frequent local ablation therapy for intrahepatic recurrence in the prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection. An analysis of 610 patients over 16 years old. Ann Surg 2006;244:265-273. (Pubitemid 44305542)
18. Poon RT, Ng KK, Lam CM, et al.: Learning curve for radiofrequency ablation of liver tumors: Prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004;239:441-449.
19. Curley SA, Marra P, Beaty K, et al.: Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458. (Pubitemid 38372760)
20. Vivarelli M, Guglielmi A, Ruzzenente A, et al.: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240:102-107. (Pubitemid 38808241)
21. Yamanaka Y, Shiraki K, Miyashita K, et al.: Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. World J Gastroenterol 2005;11:2174-2178. (Pubitemid 40542666)
22. Yu HC, Cheng JS, Lai KH, et al.: Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005;11:1439-1444. (Pubitemid 40468077)
23. Mazzaferro V, Battiston C, Perrone S, et al.: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 2004;240:900-909. (Pubitemid 39425785)
24. Tateishi R, Shiina S, Teratani T, et al.: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-1209.
25. Kim YS, Rhim H, Lim HK, et al.: Completeness of treatment in hepatocellular carcinoma treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced Ct with histopathologic correlation in the explanted liver specimen. J Comput Assist Tomogr 2006;30:578-582. (Pubitemid 44091511)
26. Hori T, Nagata K, Hasuike S: Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-981. (Pubitemid 37455785)
27. Portolani N, Tiberio GAM, Ronconi M, et al.: Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 2003;50:2179-2184. (Pubitemid 37468021)
28. Nicoli N, Casaril A, Hilal MA, et al.: A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004;188:165-167. (Pubitemid 38916736)
29. Takada Y, Kurata M, Ohkohchi N: Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003;8:332-335. (Pubitemid 37370261)
30. Seki T, Tamai T, Ikeda K, et al.: Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 2001;13:291-294. (Pubitemid 32205421)
31. Harrison LE, Koneru B, Baramipour P, et al.: Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003;197:759-764. (Pubitemid 38199577)
32. Schwarz RE, Smith DD: Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008;195:829-836. (Pubitemid 351749460)